Cue Biopharma (NASDAQ:CUE – Get Free Report) is expected to be posting its quarterly earnings results on Wednesday, March 26th. Analysts expect Cue Biopharma to post earnings of ($0.15 ...

Cue Biopharma , Inc., a pharmaceutical company with a market capitalization of $63.35 million, announced Monday the appointment of Pasha Sarraf to its board of directors. The decision, recommended ...